Photo taken from Rahul Banerjee/X
May 21, 2024, 15:48
Cancer Network – A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X:
“So much fun speaking with Saad Z. Usmani, Yi Lin, Doris Hansen about CAR-T in MMsm – and the ‘CAR-eligible’ vs ineligible pathways of the future. Although if our shirt colors are any indicator, for an RCT of CAR-T vs ‘investigator’s choice’ we’d all choose the same thing. ”
Quoting Cancer Network‘s post:
“A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy, highlighting BCMA as a target and treatment administration practices.”
Source: Rahul Banerjee/X and Cancer Network/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 31, 2025, 20:25
Mar 31, 2025, 20:25
Mar 31, 2025, 20:00
Mar 31, 2025, 19:01
Mar 31, 2025, 18:51
Mar 31, 2025, 18:40
Mar 31, 2025, 18:40